Related Experiment Video
Updated: Jun 4, 2026
06:18
An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
Published on: August 13, 2019
Update in hormone therapy use in menopause.
Hugh S Taylor1, JoAnn E Manson
1Division of Reproductive Endocrinology and Infertility, Yale University School of Medicine, New Haven, Connecticut 06520, USA.
The Journal of Clinical Endocrinology and Metabolism
|February 8, 2011
Summary
Recent analyses refine understanding of hormone therapy (HT) risks and benefits for menopausal symptom relief. New advances aim for safer, more effective HT options with improved benefit-to-risk ratios.
Area of Science:
- Reproductive Endocrinology
- Oncology
- Cardiovascular Medicine
Background:
- The Women's Health Initiative (WHI) study significantly impacted the perception of hormone therapy (HT).
- Subsequent reanalyses and new data have refined the understanding of HT's benefits and risks.
- HT remains crucial for managing menopausal vasomotor symptoms.
Purpose of the Study:
- To provide an update on recent advances in menopausal hormone therapy.
- To discuss evolving concepts regarding HT's role in cardiovascular disease and breast cancer.
- To explore new developments enhancing HT's safety and efficacy.
Main Methods:
- Review and analysis of reprocessed WHI data and additional studies.
- Examination of factors influencing HT risks and benefits, including age, timing, duration, dose, and route.
- Inclusion of emerging data on potential links between HT and other cancers.
Main Results:
- Menopausal hormone therapy remains indicated for vasomotor symptom management.
- Understanding of HT's impact on cardiovascular disease and breast cancer continues to evolve.
- Further analyses explore the persistence of risks and benefits post-therapy cessation.
Conclusions:
- Recent data suggest potential associations between HT and lung and ovarian cancers.
- New advancements in HT are anticipated to improve the benefit-to-risk profile.
- Future HT developments promise safer and more effective menopausal symptom relief.
Related Concept Videos
01:28Menopause
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
01:22Hormonal Regulation of the Menstrual Cycle
The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH release.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH release.
01:30Hormonal Control of the Ovarian Cycle
The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
01:33Hormonal Regulation
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
01:40Hormonal Regulation
Hormones regulate a significant portion of digestion through activation of the neuroendocrine system. The neuroendocrine system of digestion contains many different hormones all with multiple functions that are both, directly and indirectly, involved in digestion.
01:24Gonadal and Placental Hormones
The gonads, namely the testes in males and the ovaries in females, are pivotal in producing gonadal hormones that orchestrate the intricate processes of sexual development and reproduction.
In males, testosterone is the primary gonadal androgen. It plays a central role in the maturation of male reproductive organs — the penis and testes. Additionally, testosterone is instrumental in the development of secondary sexual characteristics — a deep voice as well as facial and pubic hair growth — and...
In males, testosterone is the primary gonadal androgen. It plays a central role in the maturation of male reproductive organs — the penis and testes. Additionally, testosterone is instrumental in the development of secondary sexual characteristics — a deep voice as well as facial and pubic hair growth — and...